Chemical Component Summary | |
---|---|
Name | Huperzine A |
Identifiers | n/a |
Formula | C15 H18 N2 O |
Molecular Weight | 242.316 |
Type | NON-POLYMER |
Isomeric SMILES | C/C=C/1\[C@@H]2CC3=C([C@]1(CC(=C2)C)N)C=CC(=O)N3 |
InChI | InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15+/m0/s1 |
InChIKey | ZRJBHWIHUMBLCN-YQEJDHNASA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 36 |
Chiral Atom Count | 2 |
Bond Count | 38 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB04864 |
---|---|
Name | Huperzine A |
Groups |
|
Description | Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss _Huperzia serrata_. The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being investigated as a possible treatment for diseases characterized by neurodegeneration – particularly Alzheimer’s disease. |
Synonyms |
|
Indication | Investigated for use/treatment in alzheimer's disease. |
Categories |
|
CAS number | 102518-79-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Acetylcholinesterase | MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRG... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL395280 |
PubChem | 854026 |
ChEMBL | CHEMBL395280 |
ChEBI | CHEBI:94624, CHEBI:78330 |
CCDC/CSD | KITMOR, QIFPEC, KINKOH, QERHOL |
COD | 4507750 |